2/3 of patients are willing to have a certain level of spectacle freedom.
It is one of the slides showing real-world data from 10K patients I've gathered at my patient education digital projects. If you were at Ophthalpreneurs 2024 in Stresa, you might remember my presentation.
Inspiring, isn't it?
What is the reason that some practices have 70-80% of premium IOLs, and some are about to reach 5..10%?
It is a few, as this is a complex question.
1. The brand, appearance and perception of the clinic. It is something, which makes initial patient flow more or less oriented towards premium lenses, service and value.
2. Your internal processes setup. The patient communication pattern, either well tailored or not, which results in different conversion % rate.
3. The technologies you use, in terms of IOL portfolio available.
From the bottom to the top, it is sorted in a way from the least important and easiest to implement to the most important and the most difficult to implement time and efforts wise.
From my experience, I can say that the most critical here is actual implementation of whatever you want to improve- either it is IOL portfolio, patient communication routine or branding.
Patient education is in the middle, and it is something you can manage by your own, especially if you are starting the business i.e. private ophthalmic practice.
If you are not happy with the conversion rate of your practice, the first point where to look at is the patient communication, which covers your
external look (web site, ads, social media etc)
internal processes (who and how talks with the patient)
final counselling on surgery and IOL options
These 3 aspects shall play a symphony of your value delivery.
A free 30-minute call with me will help you understand if your patient communication symphony needs adjustment and, if so, what the expected pathway is.
The best time to do something is right now. Contact us here to learn about your opportunities.
Oleksii Sologub
MSc, LLB, SE MBA
Entrepreneur | Board Member & Strategic Business Consultant in Ophthalmology
Comments